Conference Coverage

Interrupting oral anticoagulation in AF carries high thromboembolic cost

Publish date: November 1, 2016

 

AT THE ESC CONGRESS 2016

Pages

Recommended Reading

Similarities seen in rate and rhythm control for postsurgical AF
MDedge Neurology
AF and stroke may be temporally related
MDedge Neurology
Anticoagulation therapy after VT ablation yields fewer thrombotic events
MDedge Neurology
Exercise is protective but underutilized in atrial fib patients
MDedge Neurology
Stroke risk rises quickly in recent-onset atrial fib
MDedge Neurology
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
MDedge Neurology
Andexanet controlled factor Xa inhibitor–related bleeding
MDedge Neurology
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
MDedge Neurology
Joint European atrial fibrillation guidelines break new ground
MDedge Neurology
Adaptive servo ventilation cuts atrial fib burden
MDedge Neurology